A life sciences company can have compelling science, a strong intellectual property position, promising data, and a highly respected scientific team, yet still struggle to convince the people whose support it needs most.
Investors hesitate. Potential partners ask more questions. Candidates remain uncertain about the opportunity. Employees hear different versions of the company’s priorities depending on which executive they speak with.
Sometimes the problem is not the science. It is the story surrounding it.
In life sciences, communication is unusually difficult because the underlying subject matter is complex. A CEO may be expected to explain a scientific platform to investors, a clinical strategy to employees, a commercial opportunity to partners, and a corporate vision to candidates, often within the same week. Each audience needs something different, but the underlying message still needs to connect.
That makes executive communication more than a presentation skill. It becomes part of leadership itself.
Scientific complexity does not excuse strategic ambiguity
Scientists are trained to respect nuance. That is essential to good science, but it can create challenges when communicating outside a technical environment.
A scientific leader may be comfortable explaining uncertainty, competing hypotheses, experimental limitations, and probabilities. An investor or prospective executive may instead be trying to understand a much simpler question: Where is this company going, and why should I believe it can get there?
The answer does not require oversimplifying the science. It requires putting the science into context.
What problem is the company solving? Why does the approach matter? What has been demonstrated? What remains uncertain? What must happen next? What capabilities will the organization need to get there?
The strongest life sciences leaders can move between these levels of conversation without losing credibility in either one.
That ability becomes particularly important as companies move from research into development and commercialization. The audience expands, the stakes increase, and the organization can no longer rely on technical expertise alone to explain its value.
Every executive tells a slightly different story
One of the easiest ways for an organization to create confusion is to allow its leadership team to communicate the company’s direction independently.
The CEO talks about commercialization. The CSO emphasizes platform expansion. The CFO focuses on capital efficiency. The commercial leader discusses market opportunity. The clinical team emphasizes the next development milestone. All of these perspectives may be legitimate. The problem occurs when they do not connect.
A sophisticated candidate listening to several members of the executive team will quickly notice inconsistencies. So will an investor and a potential strategic partner. This does not mean everyone should use identical language. In fact, overly scripted communication can create its own problems. What matters is that executives understand the same strategic priorities and can explain how their functions contribute to them.
Alignment therefore has a communication dimension that is easy to underestimate.
We previously examined how communication and people leadership influence transformation in life sciences organizations. The same principle applies here: strategy becomes much harder to execute when leaders communicate different interpretations of where the organization is going.
The CEO increasingly becomes the organization’s translator
The CEO has a particularly difficult communication responsibility because the CEO sits at the intersection of multiple worlds.
Scientists want to know whether the organization is protecting scientific integrity. Investors want to understand capital allocation and potential returns. Employees want clarity about priorities and their future. Partners want confidence that the organization can execute. Candidates want to understand what they would actually be joining. These audiences are not looking for exactly the same thing. The CEO’s role is not to tell each audience a different story. It is to make the same underlying strategy meaningful to each one. That requires judgment.
A technically accurate explanation can still fail if it leaves the audience without context. Conversely, a compelling narrative can become dangerous if it moves beyond what the evidence supports. The strongest leaders understand that credibility comes from balancing ambition with precision.
Executive communication also affects hiring
The connection between corporate storytelling and executive recruitment is closer than it may appear.
Senior candidates are evaluating the organization while the organization evaluates them. They want to understand not only the position but the strategic circumstances surrounding it.
- Why is the role being created?
- What problem is the company trying to solve?
- What does the board expect from the executive?
- What happens if the next milestone is delayed?
- How much authority will the new leader actually have?
- What does success look like after 12 or 24 months?
- When those questions are answered consistently, the opportunity becomes easier to understand.
- When different stakeholders provide different answers, experienced executives notice.
This is especially important when recruiting passive candidates. A senior executive who is already successful elsewhere has little reason to take on an ambiguous opportunity simply because the science looks interesting. They are evaluating the quality of the business, the leadership team, the board, the mandate, and the likelihood that they can actually make an impact. The company’s story therefore becomes part of the candidate proposition, whether leadership intends it to or not.
The danger of a story that gets ahead of the science
There is another side to this equation. Some organizations become so focused on creating a compelling narrative that the story begins to move faster than the evidence. That can create short-term enthusiasm but long-term credibility problems.
Life sciences executives operate in an environment where claims are eventually tested. Clinical data arrives. Regulatory decisions are made. Commercial assumptions meet the market. Manufacturing challenges emerge.
A leadership team that consistently communicates with appropriate confidence while acknowledging uncertainty can build trust even when outcomes are imperfect. A team that repeatedly overstates certainty risks losing that trust when reality catches up. Good communication does not make uncertainty disappear. It makes uncertainty understandable.
The best stories are built around decisions, not slogans
A company’s strategy becomes more credible when leadership can explain the decisions behind it.
- Why this indication?
- Why this development sequence?
- Why this partnership?
- Why this market?
- Why invest in this capability now?
- Why hire this executive at this stage?
These questions reveal whether the company’s narrative is connected to actual strategic choices. That is where communication becomes particularly useful to executive leadership. A clear story is not simply something used externally. It forces the leadership team to clarify its own thinking. If executives cannot explain why a decision was made, the communication problem may actually be a strategy problem. And if they can explain it clearly, consistently, and without resorting to corporate language, they are much more likely to bring investors, employees, partners, and future executives along with them.
Leadership credibility is built in the space between the facts
The most effective life sciences leaders do not need to make complicated science sound simple. They need to make its significance clear. They connect scientific progress to business strategy, business strategy to organizational capability, and organizational capability to the people required to execute it. That is where the story becomes more than marketing. It becomes leadership.
The science may be the reason a company exists. But the ability to explain where that science can go, what stands between the company and that destination, and what leadership is required to get there can determine whether others are willing to make the journey with it.
For CEOs and boards, that makes communication worth considering as an executive capability in its own right and not simply an attractive characteristic added to an otherwise complete leadership profile.
GeneCoda® works with life sciences founders, CEOs, and boards to identify executives who can translate complex scientific and commercial challenges into clear direction and disciplined execution. If your organization is entering a new phase of growth and the leadership story needs to be as strong as the science, contact us to discuss your executive leadership needs.
